Telix Pharmaceuticals Ltd
TLX · TLPPF · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Smith Darren Charlton: Form 4
Insider disclosure · Filed · Report period 07 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- TLX · 87961M105 - Ordinary Shares
Company details and SEC sources
CIK 0002007191 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- TLX on Nasdaq, TLPPF on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 55 Flemington Road, North Melbourne, Australia, 3051
- Incorporated in
- Australia
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields